Current updates on generations, approvals, and clinical trials of CAR T-cell therapy

• Main Authors: Tadesse Asmamaw Dejenie (Author), Markeshaw Tiruneh G/Medhin (Author), Gashaw Dessie Terefe (Author), Fitalew Tadele Admasu (Author), Wondwossen Wale Tesega (Author), Endeshaw Chekol Abebe (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Chimeric antigen receptor (CAR) T-cell therapy is a novel, customized immunotherapy that is considered a 'living' and self-replicating drug to treat cancer, sometimes resulting in a complete cure. CAR T-cells are manufactured through genetic engineering of T-cells by equipping them with CA...